30 results
8-K
EX-99.2
XLO
Xilio Therapeutics Inc
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
milestones and value-drivers while seeking to deliver on the long-term promise of our differentiated research platform and capabilities. I extend sincere
8-K
EX-99.1
t1c1k3g08y7 3k1
3 Nov 23
Other Events
4:05pm
8-K
EX-99.2
3qdm96weci0am5pjaq
14 Aug 23
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
7:40am
8-K
EX-99.1
hulhb6
25 May 23
Regulation FD Disclosure
5:05pm
8-K
EX-10.1
ldhq1i2cu53bacukl
3 Apr 23
Departure of Directors or Certain Officers
4:05pm
S-3
EX-1.2
kn0clh24kk 0e3m
9 Nov 22
Shelf registration
4:15pm
8-K
EX-99.2
b3betjccva07gc0ya202
9 Nov 22
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2022 Financial Results
7:45am
8-K
EX-99.2
zwqzc7
12 May 22
Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results
7:36am
DEF 14A
29mqjf1bhw wvu9y
26 Apr 22
Definitive proxy
4:05pm